NL-OMON56551
招募中
不适用
Elective cardioversion of atrial fibrillation at home by advanced practice providers; A feasibility study in Dutch emergency medical service. - ELECTRA-1
Jeroen Bosch ziekenhuis0 个研究点目标入组 25 人待定
概览
- 阶段
- 不适用
- 干预措施
- 未指定
- 疾病 / 适应症
- atrial fibrilation
- 发起方
- Jeroen Bosch ziekenhuis
- 入组人数
- 25
- 状态
- 招募中
- 最后更新
- 2年前
概览
简要总结
暂无简介。
研究者
入排标准
入选标准
- •1\. 1\. Signed informed consent 2\. Age 18 \-75 year subjects, able to understand
- •the provided information and sign an informed consent 3\. Need for direct
- •current electrical cardioversion (DC\-ECV) for correction of recurrent
- •symptomatic AF (according to the guidelines of the American College of
- •Cardiology/American Heart Association/European Society of Cardiology
- •(ACC/AHA/ESC)). 4\. Weight more than 50 kilograms 5\. Successful hospital DC\-ECV
- •for a previous episode of AF performed under propofol sedation 6\. Target range
- •of international normalized ratio (INR) above 2\.0, when on vitamin K
- •antagonists, or use of novel oral anticoagulant, stable for 3 weeks 7\. ASA 2 8\.
- •BMI \< 35 kg/m2
排除标准
- •1\. Patients over 75 years old and younger than 18 years 2\. Patients wearing
- •pacemaker or implantable cardioverter\-defibrillator. 3\. Patients with
- •(cardiovascular): \* sick sinus syndrome, ventricular pre\-excitation, Brugada
- •syndrome or bundle branch block \* severe ischemic or valvular heart disease \*
- •known second or third degree atrioventricular block normal sinus rhythm \* heart
- •failure NYHA III or IV, known LVEF \< 35%, or cor pulmonale \* transient and
- •reversible cause of AF, e.g. in setting of fever and hyperthyroidism 4\.
- •Patients with severe co\-morbidities: a. liver disease b. kidney impairment
- •(eGFR \<\= 30 according to formula MDRD) c. pulmonary dysfunction (FEV1 /VC \<75%
- •gold classification) d. active malignancy e. connective tissue disease f.
结局指标
主要结局
未指定
相似试验
招募中
不适用
A new way of selecting atrial electrograms for ablatioAtrial fibrillationCardiovascular - Other cardiovascular diseasesACTRN12612001224819Prof Prash Sanders, Dr Anand Ganesan20
尚未招募
不适用
CAtheter-Based Ablation of atrial fibrillation compared to conventional treatment in patients with Heart Failure with Preserved Ejection Fraction - Investigator-initiated, prospective, parallel-group, randomized, open, blinded endpoint assessment (PROBE), interventional multicenter strategy trialAtrial fibrillation and HFpEFheart failure with a preserved ejection fraction10007521NL-OMON56877Charité Universitätsmedizin Berlin150
已完成
不适用
Management of Atrial fibriLLation INcluding tailoring of anticoagulation in patients from primary care - ALL-Iabnormal heart rhythma-fib10007521NL-OMON44028Isala Klinieken Zwolle1,000
已完成
不适用
Integrated management of the heart rhythm disorder atrial fibrillation, including stroke prevention with blood thinners and care for comorbidities, by the practice nurse and general practitioner in primary careAtrial fibrillation, anticoagulation, comorbidity, integrated care, primary care. Atriumfibrilleren, antistolling, comorbiditeit, integrale zorg, eerste lijn.NL-OMON23738Sponsor (verrichter) is the Isala hospital, Zwolle, the Netherlands. Performer (uitvoerder) is the Julius Center for Health Sciences and Primary Care of the University Medical Center Utrecht, The Netherlands.1,000
已完成
不适用
Presence of Sub-Clinical Atrial Fibrillation using an implantable cardiac monitor in patients with cardiovascular risk factors (ASSERT II)atrial fibrillationpalpitations10007521NL-OMON41317Population Health Research Institute of Hamilton Health Sciences150